Open AccessCumulative exposure to ritonavir-boosted atazanavir is associated with cholelithiasis in patients with HIV-1 infection
Author(s) -
Takeshi Nishijima,
Takuro Shimbo,
Hirokazu Komatsu,
Yohei Hamada,
Hiroyuki Gatanaga,
Yoshimi Kikuchi,
Shinichi Oka
Publication year - 2013
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkt514
Subject(s) - atazanavir , ritonavir , darunavir , lopinavir , medicine , univariate analysis , gastroenterology , multivariate analysis , virology , human immunodeficiency virus (hiv) , viral load , antiretroviral therapy
This study aimed to examine the effect of long-term treatment with ritonavir-boosted atazanavir (atazanavir/ritonavir) on cholelithiasis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom